Market Tracker

05/28 4:08pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

40.11
Delayed Data
As of 3:52pm ET
 -0.71 / -1.74%
Today’s Change
19.21
Today|||52-Week Range
46.48
+26.33%
Year-to-Date

Today’s Trading

Previous close40.82
Today’s open40.67
Day’s range39.55 - 40.79
Volume767,336
Average volume (3 months)2,105,463
Market cap$4.1B
Dividend yield--
Data as of 3:52pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-41.99%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book13.20

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.03+0.09%
NBIXNeurocrine Bioscienc...-0.24-0.56%
IPXLImpax Laboratories I...+0.54+1.17%
CLVSClovis Oncology Inc-3.20-3.42%
Data as of 3:53pm ET, 05/28/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger G. Mills
Corporate headquarters
San Diego, California

Forecasts